top of page

Dr. Heather Hipp is a Reproductive Endocrinologist and Infertility specialist at Emory University. She graduated from Duke University with double majors in Biology and English. She then worked at the National Institutes of Health in Rockville, Maryland for two years, studying genetic associations with addiction disorders and chronic pain. Following this basic science research, she matriculated at Emory University for her M.D and graduated cum laude. She stayed at Emory for her residency in Gynecology and Obstetrics and her fellowship in Reproductive Endocrinology and Infertility. She is currently an Assistant Professor at Emory University School of Medicine. She is actively involved in clinical care of her patients at Emory Reproductive Center and has introduced a Reproductive Endocrine clinic at Grady Memorial Hospital, where she works once a week, caring for an underserved population. She currently serves as the Subspecialty Resident Educator for the Emory OB/ Gyn residents for their REI rotations and is on the Resident Clinical Competency and Program Evaluation Committees.

Dr. Hipp has won multiple clinician, teaching and patient satisfaction awards and was awarded membership in the Alpha Omega Alpha National Medical Honor Society. Professional Memberships include the American College of Obstetrics and Gynecology, American Society for Reproductive Medicine, Alpha Omega Alpha Honor Society, and Georgia OB/ Gyn Society.

Dr. Hipp’s prior research has focused on women who are carriers for the fragile X mutation and their risk of Primary Ovarian Insufficiency. She is on the National Fragile X Foundation Scientific and Clinical Advisory Committee. She has also published work on national trends and outcomes of in-vitro fertilization (IVF) using data from the Centers for Disease Control’s National Assisted Reproductive Technology surveillance system. Dr. Hipp has presented her work in multiple peer-reviewed journals and at national scientific and clinical meetings, including American Society for Reproductive Medicine and the International Fragile X Conference.

bottom of page